Core Viewpoint - The approval of the "Monkey's Paw Phlegm-Removing Powder" for mainland market entry marks a significant milestone for the company, reflecting the effectiveness of the simplified registration policy for traditional Chinese medicine in Hong Kong and Macau [1] Company Summary - The company's stock, Bit Yuan Tang (00897), rose over 11%, reaching a price of 0.49 HKD with a trading volume of 2.53 million HKD [1] - The company’s flagship products include the "An Gong Niu Huang Wan" series, the classic "Yang Yin Wan," and the "Monkey's Paw Phlegm-Removing Powder," which has been a sales champion for ten consecutive years [1] Industry Summary - The approval of the product is the first instance of a traditional Chinese medicine being granted entry into the mainland market under the new simplified registration policy, indicating a positive trend for the industry [1]
港股异动 | 位元堂(00897)涨超11% 猴枣除痰散通过简化注册审批政策获批内地上市